East Bay Parkinson's drug maker to be swallowed up in potential $450M deal

The acquisition, expected to close by the end of this year or early 2022, includes $400 million in upfront payments.

Source: bizjournals.com Health Care:Biotechnology headlines - October 11, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news